Michael Catelani, President at Anixa Biosciences Inc (ANIX), bought 2,509 shares at $2.53 ($6K) on 2022-04-20, disclosed to the SEC on 2022-04-21.
Open-market purchase of $6k ANIX by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ANIX | BUY | 2024-06-07 | $15K | — | Filing → |
| ANIX | BUY | 2023-07-21 | $20K | — | Filing → |
| ANIX | BUY | 2022-04-22 | $15K | — | Filing → |